These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3576 related articles for article (PubMed ID: 20530316)

  • 1. Human papillomavirus and survival of patients with oropharyngeal cancer.
    Ang KK; Harris J; Wheeler R; Weber R; Rosenthal DI; Nguyen-Tân PF; Westra WH; Chung CH; Jordan RC; Lu C; Kim H; Axelrod R; Silverman CC; Redmond KP; Gillison ML
    N Engl J Med; 2010 Jul; 363(1):24-35. PubMed ID: 20530316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Smoking in Human Papillomavirus-Positive Oropharyngeal Cancer Under American Joint Committee on Cancer Eighth Edition Stage.
    Chidambaram S; Nakken ER; Kennedy W; Thorstad WL; Chen SY; Pipkorn P; Zevallos JP; Mazul AL
    Laryngoscope; 2020 Aug; 130(8):1961-1966. PubMed ID: 32293733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.
    Sedaghat AR; Zhang Z; Begum S; Palermo R; Best S; Ulmer KM; Levine M; Zinreich E; Messing BP; Gold D; Wu AA; Niparko KJ; Kowalski J; Hirata RM; Saunders JR; Westra WH; Pai SI
    Laryngoscope; 2009 Aug; 119(8):1542-9. PubMed ID: 19522004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
    Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
    J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.
    Fakhry C; Zhang Q; Gillison ML; Nguyen-Tân PF; Rosenthal DI; Weber RS; Lambert L; Trotti AM; Barrett WL; Thorstad WL; Yom SS; Wong SJ; Ridge JA; Rao SSD; Spencer S; Fortin A; Raben D; Harris J; Le QT
    Cancer; 2019 Jun; 125(12):2027-2038. PubMed ID: 30913305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Hawkins PG; Mierzwa ML; Bellile E; Jackson WC; Malloy KM; Chinn SB; Spector ME; Shuman AG; Stucken CL; McLean SA; Bradford CR; Prince ME; Carey TE; Worden FP; Swiecicki PL; Taylor JMG; Wolf GT; Eisbruch A; Casper KA
    Head Neck; 2019 Apr; 41(4):857-864. PubMed ID: 30775826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
    Gillison ML; Trotti AM; Harris J; Eisbruch A; Harari PM; Adelstein DJ; Jordan RCK; Zhao W; Sturgis EM; Burtness B; Ridge JA; Ringash J; Galvin J; Yao M; Koyfman SA; Blakaj DM; Razaq MA; Colevas AD; Beitler JJ; Jones CU; Dunlap NE; Seaward SA; Spencer S; Galloway TJ; Phan J; Dignam JJ; Le QT
    Lancet; 2019 Jan; 393(10166):40-50. PubMed ID: 30449625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
    Elhalawani H; Mohamed ASR; Elgohari B; Lin TA; Sikora AG; Lai SY; Abusaif A; Phan J; Morrison WH; Gunn GB; Rosenthal DI; Garden AS; Fuller CD; Sandulache VC
    BMC Cancer; 2020 Sep; 20(1):912. PubMed ID: 32967643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.
    Yin LX; D'Souza G; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig EM; Ryan WR; Ha PK; Wentz A; Koch W; Eisele DW; Fakhry C
    Laryngoscope; 2018 Aug; 128(8):E287-E295. PubMed ID: 29536542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy in Metastatic Oropharyngeal Cancer.
    Nguy S; Oh C; Karp JM; Wu SP; Li Z; Persky MJ; Hu KS; Givi B; Tam MM
    Laryngoscope; 2021 Jun; 131(6):E1847-E1853. PubMed ID: 33141455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking.
    Lilja-Fischer JK; Eriksen JG; Georgsen JB; Vo TT; Larsen SR; Cheng J; Busch-Sørensen M; Aurora-Garg D; Steiniche T; Overgaard J
    Acta Oncol; 2020 Jun; 59(6):666-672. PubMed ID: 32079442
    [No Abstract]   [Full Text] [Related]  

  • 12. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
    Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
    J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of time to simulation and treatment for patients with oropharyngeal cancer receiving definitive radiotherapy in the era of risk stratification using smoking and human papillomavirus status.
    Amsbaugh MJ; Yusuf M; Cash E; Silverman C; Potts K; Dunlap N
    Head Neck; 2018 Apr; 40(4):687-695. PubMed ID: 29356189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of High-Risk Pathologic Features in HPV-Related Oropharyngeal Squamous Cell Carcinoma and Tobacco Use.
    Kompelli AR; Morgan P; Li H; Harris W; Day TA; Neskey DM
    Otolaryngol Head Neck Surg; 2019 May; 160(5):855-861. PubMed ID: 30526292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.
    Mackenzie P; Pryor D; Burmeister E; Foote M; Panizza B; Burmeister B; Porceddu S
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):643-7. PubMed ID: 25001635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma.
    Liskamp CP; Janssens GO; Bussink J; Melchers WJ; Kaanders JH; Verhoef CG
    Head Neck; 2016 Dec; 38(12):1780-1787. PubMed ID: 27248701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
    Ang KK; Sturgis EM
    Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Mizumachi T; Kano S; Sakashita T; Hatakeyama H; Suzuki S; Homma A; Oridate N; Fukuda S
    Int J Clin Oncol; 2013 Oct; 18(5):824-8. PubMed ID: 22936564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 179.